Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.57	39.88	45.28	27.35	22.06
Short-Term Investments	89.02	79.23	172.29	164.07	32.07
Cash & Short-Term Investments	113.59	119.11	217.57	191.41	54.13
Cash Growth	-4.63%	-45.26%	13.66%	253.61%	-26.12%
Receivables	8.92	0.3	0.48	0.62	0.77
Prepaid Expenses	3.44	9.45	13.5	13	2.59
Total Current Assets	125.95	128.86	231.55	205.03	57.49
Property, Plant & Equipment	3.85	5.48	3.78	4.77	5.78
Long-Term Investments	90.3	62.77	12.24	34.24	-
Other Intangible Assets	-	-	6.97	7.05	7.12
Other Long-Term Assets	0.22	0.3	0.05	0.12	0.39
Total Assets	220.33	197.41	254.6	251.21	70.78
Accounts Payable	4.69	8.88	10.35	9.99	5.25
Accrued Expenses	7.6	10.86	8.2	7.37	5.91
Current Portion of Leases	0.48	0.43	0.68	0.72	0.6
Current Unearned Revenue	3.89	-	-	-	-
Other Current Liabilities	14.94	10.79	2.7	4.85	3.11
Total Current Liabilities	31.6	30.95	21.94	22.93	14.87
Long-Term Debt	-	-	-	-	10.65
Long-Term Leases	2.12	3.07	1.57	2.17	2.89
Long-Term Unearned Revenue	20.04	-	-	-	-
Long-Term Deferred Tax Liabilities	-	-	0.37	0.37	0.37
Other Long-Term Liabilities	11.02	6.2	33.1	28.4	4.35
Total Liabilities	64.77	40.23	56.98	53.87	33.13
Common Stock	0	0	0	0	-
Additional Paid-In Capital	1,058	928.08	880.83	792.97	542.29
Retained Earnings	-902.86	-770.8	-682.32	-595.41	-504.54
Comprehensive Income & Other	0.1	-0.11	-0.9	-0.22	-0.09
Total Common Equity	155.55	157.18	197.62	197.34	37.65
Shareholders' Equity	155.55	157.18	197.62	197.34	37.65
Total Liabilities & Equity	220.33	197.41	254.6	251.21	70.78
Total Debt	2.6	3.5	2.25	2.89	14.15
Net Cash (Debt)	201.3	178.38	227.56	222.76	39.98
Net Cash Growth	12.85%	-21.61%	2.15%	457.17%	-42.11%
Net Cash Per Share	2.60	2.56	3.49	3.93	0.94
Filing Date Shares Outstanding	107.92	70.93	66.69	61.28	51.8
Total Common Shares Outstanding	107.85	70.89	66.69	61.23	45.11
Working Capital	94.36	97.9	209.61	182.1	42.62
Book Value Per Share	1.44	2.22	2.96	3.22	0.83
Tangible Book Value	155.55	157.18	190.65	190.29	30.53
Tangible Book Value Per Share	1.44	2.22	2.86	3.11	0.68
Machinery	5	4.97	4.01	3.61	3.15
Leasehold Improvements	0.82	0.82	1.12	1.12	1.12

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q